image
Healthcare - Biotechnology - NASDAQ - US
$ 0.5401
-6.54 %
$ 67.4 M
Market Cap
-0.33
P/E
BALANCE SHEET
143 M ASSETS
-27.88%
46.2 M LIABILITIES
-2.48%
96.7 M EQUITY
-35.87%
BALANCE SHEET DECOMPOSITION
Balance Sheet Vor Biopharma Inc.
image
Current Assets 96.5 M
Cash & Short-Term Investments 91.9 M
Receivables 0
Other Current Assets 4.58 M
Non-Current Assets 46.4 M
Long-Term Investments 0
PP&E 41.6 M
Other Non-Current Assets 4.8 M
64.33 %3.21 %29.10 %3.36 %Total Assets$142.9m
Current Liabilities 18.6 M
Accounts Payable 1.5 M
Short-Term Debt 4.22 M
Other Current Liabilities 12.9 M
Non-Current Liabilities 27.6 M
Long-Term Debt 0
Other Non-Current Liabilities 27.6 M
3.26 %9.12 %27.89 %59.74 %Total Liabilities$46.2m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 81.9 31.4 57.7 119.8 48.5 6.5 0.9
Short Term Investments 10.0 105.8 172.5 87.7 0 0 0
Receivables 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0
Other Current Assets 0.4 3.6 6.7 6.9 0.6 1.1 7 K
Total Current Assets 96.5 140.8 236.9 214.4 49.1 7.5 0.9
PP&E 41.6 50.1 57.1 22.5 21.8 0.7 71 K
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 2.4 2.4 1.6 1.6 0
Other Long Term Assets 4.8 7.2 2.9 3.3 3.4 0 0
Other Assets 0 0 0 0 0 0 0
Total Assets 142.9 198.1 299.4 242.6 75.9 9.8 1.0
LIABILITIES
Accounts Payable 1.5 0.8 1.8 1.5 2.4 0.7 38 K
Short Term Debt 4.2 3.8 6.5 3.7 1.7 0 4.5
Other Current Liabilities 12.9 10.9 4.8 4.9 6.1 1.5 3.3
Total Current Liabilities 18.6 15.6 13.1 10.2 10.2 2.2 7.8
Long Term Debt 0 31.8 71.3 32.3 34.9 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 (35.6) (16.2) (17.4) 0 0
Total Liabilities 46.2 47.4 48.8 26.3 27.6 2.2 7.8
EQUITY
Common Stock 13 K 7 K 7 K 4 K 1 K 0 0
Retained Earnings (457.0) (340.1) (222.2) (130.1) (61.2) (17.9) (7.0)
Other Accumulative Comprehensive Income/Loss 22 K 77 K (0.8) (242.6) 0 0 0
Total Equity 96.7 150.7 250.6 216.3 48.3 7.6 (6.8)
Total Liabilities and Equity 142.9 198.1 299.4 242.6 75.9 9.8 1.0
SHARES OUTSTANDING
Common Shares Outstanding 68.7 67.2 39.6 37.2 37.1 37.1 5.7